Edward J Dulac III

FATE

Edward J Dulac III serves as EVP, Chief Financial Officer at Fate Therapeutics, Inc. (FATE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

15 trades

$3.04M

Net Position

Net Seller

$3.04M

Companies Traded

NTLA, FATE

Active Period

Aug 2021 – Jan 2026

15 total trades

Most Recent

Sell NTLA

Jan 5, 2026 · $58.8K

Edward J Dulac III's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

0 · $0.00

Sells

13 · $2.88M

Total Shares Bought

Total Shares Sold

81,138

FATE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 5, 2024	Sell	2,447	$7.77	$19.0K	101,479
Jan 30, 2024	Sell	1,849	$5.00	$9.2K	103,926
Jan 10, 2024	Sell	7,028	$4.37	$30.7K	105,775
Jan 3, 2024	Sell	5,182	$3.66	$19.0K	112,803
Dec 19, 2023	Sell	1,585	$3.50	$5.5K	117,985
Aug 21, 2023	Sell	4,718	$2.80	$13.2K	119,570
Jul 6, 2023	Sell	5,182	$4.83	$25.0K	124,288
Jan 11, 2023	Sell	7,331	$5.24	$38.4K	129,470
Aug 19, 2022	Sell	5,135	$29.81	$153.1K	137,233
Jan 13, 2022	Sell	1,770	$48.45	$85.8K	109,024
Dec 21, 2021	Sell	15,977	$60.00	$958.6K	110,404
Sep 30, 2021	Sell	19,460	$62.53	$1.22M	52,404
Aug 20, 2021	Sell	3,474	$88.26	$306.6K	56,076